IP Library Assignment 050182/0313
Patent Assignment
Reel/Frame 050182/0313

Assignment of Assignor's Interest

Recorded: 2019-08-27 Pages: 6
Assignor
SANOFI WINTHROP INDUSTRIE S.A.
Executed: 2017-09-14
Assignee
CANCER PREVENTION PHARMACEUTICALS, INC.
1760 E. RIVER ROAD, SUITE 250, TUCSON, ARIZONA, 85718
Covered Property (1)
Eflornithine and Sulindac, Fixed Dose Combination Formulation
Application: 15/771,484 →
Publication: US 2020/0009098
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 27, 2019
From: SHANNON, PATRICK
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 050181/0981 →
Assignment of Assignor's Interest Aug 27, 2019
From: DUCASSOU, JEAN
To: SANOFI WINTHROP INDUSTRIE
Reel/Frame 050182/0080 →
Assignment of Assignor's Interest Aug 27, 2019
From: BRAVO GONZALEZ, ROBERTO CARLOS
To: TILLOTTS PHARMA AG
Reel/Frame 050182/0204 →
Assignment of Assignor's Interest Aug 27, 2019
From: TILLOTTS PHARMA AG
To: CANCER PREVENTION PHARMACEUTICALS, INC.
Reel/Frame 050182/0534 →
Assignment of Assignor's Interest Oct 30, 2025
From: PANBELA THERAPEUTICS, INC.; PANBELA RESEARCH, INC.; CANCER PREVENTION PHARMACEUTICALS, INC.
To: CREATIVE PLANNING BUSINESS ALLIANCE LLC
Reel/Frame 072735/0859 →
Assignment of Assignor's Interest Nov 3, 2025
From: CREATIVE PLANNING BUSINESS ALLIANCE, LLC
To: USWM, LLC
Reel/Frame 072766/0028 →